Yotta Biomed LLC

Yotta Biomed LLC, a minority-owned, Asian-Pacific American-owned sole proprietorship based in Bethesda, Maryland, provides bioinformatics analytical support and RNA sequencing analysis services to federal research agencies exclusively as a prime contractor on GSA Multiple Award Schedule task orders, with no subcontract footprint. The firm competes in full-and-open federal procurements without set-aside designation, operating across NAICS 541512 (Custom Computer Programming Services) and related scientific consulting categories with a primary PSC coding for professional support services.

Yotta Biomed's customer base concentrates heavily within the National Institutes of Health. The top five funding components account for 73% of awards by count and 95% of combined potential value, led by NIDDK (13 awards, $1.2 million combined potential value), NIDCR (7 awards, $169 thousand), NINR (4 awards, $227 thousand), NHLBI (5 awards, $67 thousand), and NIEHS (3 awards, $113 thousand). A single GSA Federal Acquisition Service award for $2.7 million in combined potential value represents an outlier in the portfolio composition; the bulk of Yotta Biomed's revenue derives from multiple small NIH institute task orders placed under GSA MAS, where 19 task orders carry $844 thousand in combined potential value. The firm also holds a blanket purchase agreement with HHSN263201600112B under which two task orders worth $30 thousand have been issued.

Representative capability work includes a $240 thousand delivery order from NIDDK for bioinformatics and analytical support issued in April 2022 with completion in March 2024; a $90 thousand NIDDK task order from April 2024 for bioinformatics support services through March 2025; and a $26.832 thousand NIDCR delivery order in October 2024 for bioinformatics analytical support. The April 2026 NIDCR award of $15.750 thousand for RNA sequencing analysis, pipeline development, and transcriptomic data interpretation in chronic pain research (completion October 2026) represents the most recent contract activity. Work is performed primarily at Westlake and Bethesda, Maryland.

Activity has been sporadic and low-volume — one award in 2021, four in 2022, one in 2023, three in 2024, and one in early 2026 — across a total of 44 prime awards with combined potential value of $5.8 million and $1.9 million obligated to date. Only one award with combined potential value of $16 thousand faces ultimate completion within the next twenty-four months, limiting near-term recompete exposure. All awards avoid set-aside designation, positioning Yotta Biomed as a full-and-open competitor within the federal bioinformatics and life sciences research support space.

t Yotta Biomed, LLC., we provide high quality customized bioinformatics solutions to our customers for their unique needs. We provide customized bioinformatics analysis for DNA-seq, RNA-seq, and CHIP-seq. You will work with a Ph.D. level bioinformatician directly. If you have not done your sequencing yet, we will provide customized consultation, for example, which sequencing technology works best for your project, which sequencing center fits best for your project, etc. We assemble genomes, annotate genes and proteins, carry out Pathway analysis and Gene Ontology. You may want to analyze your data by yourself. However, software installation and big data management may be your bottleneck. You no longer need to buy expensive servers and big hard drives. We provide Cloud Solutions for next generation sequencing based on Amazon Cloud. We also provide education, training, consulting, and software development.